Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.750
+0.090 (3.38%)
At close: May 12, 2025, 4:00 PM
2.840
+0.090 (3.27%)
After-hours: May 12, 2025, 4:08 PM EDT
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $182.95 million as of May 12, 2025. Its market cap has decreased by -2.06% in one year.
Market Cap
182.95M
Enterprise Value
98.43M
1-Year Change
-2.06%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since June 20, 2007, Cardiff Oncology's market cap has decreased from $1.11B to $182.95M, a decrease of -83.50%. That is a compound annual growth rate of -9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 177.00M | -20.23% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 166.40% |
| Dec 30, 2011 | 36.90M | 5.73% |
| Dec 31, 2010 | 34.90M | -93.61% |
| Dec 31, 2008 | 546.30M | -50.74% |
| Dec 31, 2007 | 1.11B | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.46B |
| Johnson & Johnson | 372.99B |
| UnitedHealth Group | 343.97B |
| AbbVie | 338.64B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.68B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |